Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 11 , ISSUE 4 ( July-August, 2019 ) > List of Articles

CASE REPORT

Parenchymal Splenic Metastasis from Ovarian Cancer: A Report of Two Cases and Literature Review

Mohammad Zuhdy, Khaled Gaballa, Omar Hamdy, Reham Alghandour, Mohamed G Elmadawy, Yasmin N Laimon, Gehad A Saleh, Mahmoud M Saleh, Amr Hosam

Keywords : Case report, Ovarian cancer, Splenic metastasis

Citation Information : Zuhdy M, Gaballa K, Hamdy O, Alghandour R, Elmadawy MG, Laimon YN, Saleh GA, Saleh MM, Hosam A. Parenchymal Splenic Metastasis from Ovarian Cancer: A Report of Two Cases and Literature Review. J South Asian Feder Obs Gynae 2019; 11 (4):273-277.

DOI: 10.5005/jp-journals-10006-1701

License: CC BY-NC 4.0

Published Online: 01-12-2016

Copyright Statement:  Copyright © 2019; The Author(s).


Abstract

Aim: We report two cases of splenic metastasis from ovarian cancer. Background: Parenchymal splenic metastasis from ovarian cancer is rarely encountered. Case description: Two cases of ovarian serous carcinoma presented by isolated recurrent parenchymal splenic metastasis that was managed by splenectomy as secondary cytoreductive surgery. Conclusion: Thorough follow-up of ovarian cancer cases including careful clinical examination, computed tomography (CT), and tumor markers assessment, when clinically indicated, can early detect any recurrence events even isolated splenic recurrence. Clinical significance: Although being rare, parenchymal splenic metastasis from ovarian cancer should be suspected in advanced stage ovarian cancer.


HTML PDF Share
  1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394–424. DOI: 10.3322/caac.21492.
  2. Eisenkop SM, Spirtos NM, Friedman RL, et al. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol 2003;90(2):390–396. DOI: 10.1016/S0090-8258(03)00278-6.
  3. Berge T. Splenic metastases: frequencies and patterns. APMIS 1974;82(4):499–506.
  4. Kraus MD, Fleming MD, Vonderheide RH. The spleen as a diagnostic specimen: a review of 10 years’ experience at two tertiary care institutions. Cancer 2001;91(11):2001–2009. DOI: 10.1002/1097-0142(20010601)91:11<2001::AID-CNCR1225>3.0.CO;2-3.
  5. Fleming GRB, Seidma J, Zaino R, et al. Epithelial ovarian cancer. In: Barakat RR, Markman M, Randall M, (ed.) Principles and Practice of Gynecologic Oncology. Wolters Kluwer Health/Lippincott Williams & Wilkins; 2009. pp. 763–836.
  6. Magtibay PM, Adams PB, Silverman MB, et al. Splenectomy as part of cytoreductive surgery in ovarian cancer. Gynecol Oncol 2006;102(2):369–374. DOI: 10.1016/j.ygyno.2006.03.028.
  7. Ghani AA, Hashmi ZA, Chase DM, et al. Intraparenchymal metastases to the spleen from ovarian cancer: a case report. J Med Case Rep 2010;4(1):30. DOI: 10.1186/1752-1947-4-30.
  8. Farias-Eisner R, Braly P, Berek JS. Solitary recurrent metastasis of epithelial ovarian cancer in the spleen. Gynecol Oncol 1993;48(3): 338–341. DOI: 10.1006/gyno.1993.1059.
  9. Otrock Z, Seoud M, Khalifeh M, et al. Laparoscopic splenectomy for isolated parenchymal splenic metastasis of ovarian cancer. Int J Gynecol Cancer 2006;16(5):1933–1935. DOI: 10.1111/j.1525-1438.2006.00662.x.
  10. Lam K, Tang V. Metastatic tumors to the spleen: a 25-year clinicopathologic study. Arch Pathol Lab Med 2000;124(4):526–530.
  11. Kataoka A, Nishida T, Sugiyama T, et al. A study on the distribution of metastases at autopsy in 70 patients with ovarian cancer. Nihon Shokakibyo Gakkai Zasshi 1994;46(4):337–344.
  12. Compérat E, Bardier-Dupas A, Camparo P, et al. Splenic metastases: clinicopathologic presentation, differential diagnosis, and pathogenesis. Arch Pathol Lab Med 2007;131(6):965–969.
  13. Lv M, Li Y, Luo C, et al. Splenic metastasis of ovarian clear cell adenocarcinoma: a case report and review of the literature. Exp Ther Med 2014;7(4):982–986. DOI: 10.3892/etm.2014.1500.
  14. Klinger P, Smith SL, Abendstein BJ, et al. Hand-assisted laparoscopic splenectomy for isolated splenic metastasis from an ovarian carcinoma: a case report with review of the literature. Surg Laparo Endo Per 1998;8(1):49–54. DOI: 10.1097/00019509-199802000-00012.
  15. Gemignani M, Chi D, Gurin C, et al. Splenectomy in recurrent epithelial ovarian cancer. Gynecol Oncol 1999;72(3):407–410. DOI: 10.1006/gyno.1998.5141.
  16. Ushijima K, Nishida T, Okura N, et al. Solitary splenic recurrence of ovarian cancer: case report and review of the literature. Arch Gynecol Obstet 1999;263(1–2):79–81. DOI: 10.1007/s004040050268.
  17. Yano H, Iwazawa T, Kinuta M, et al. Solitary splenic metastasis from ovarian cancer successfully treated by hand-assisted laparoscopic splenectomy: report of a case. Surg Today 2002;32(8):750–752. DOI: 10.1007/s005950200142.
  18. Koh YS, Kim JC, Cho CK. Splenectomy for solitary splenic metastasis of ovarian cancer. BMC Cancer 2004;4(1):96. DOI: 10.1186/1471-2407-4-96.
  19. Tserkezoglou A, Kontou S, Hatjieleftheriou G, et al. Solitary parenchymal splenic recurrence of ovarian adenocarcinoma: a case report and review of the literature. Anticancer Res 2005;25(2B):1471–1476.
  20. Furukawa N. Solitary splenic metastasis of ovarian cancer. Arch Gynecol Obstet 2007;275(6):499–502. DOI: 10.1007/s00404-006-0274-4.
  21. Alloni R, Garberini A, Caputo D, et al. Solitary splenic metastasis of ovarian carcinoma: report of two cases. Surg Today 2008;38(12): 1144–1147. DOI: 10.1007/s00595-007-3747-6.
  22. Yoshioka R, Okabayashi T, Nishimori I, et al. A long-survived case with solitary splenic metastasis from ovarian carcinoma. Surg Technol Int 2008;17:192–194.
  23. Olsen AB, Pargman S, Gillespie T. Solitary splenic metastasis from ovarian carcinosarcoma: a case report. J Med Case Rep 2011;5(1):56. DOI: 10.1186/1752-1947-5-56.
  24. Yasuda K, Yoshimura T, Kitade H, et al. Laparoscopic splenectomy for solitary splenic metastasis in a patient with ovarian cancer with a long disease-free interval: a case report. J Med Case Rep 2018;12(1):132. DOI: 10.1186/s13256-018-1673-4.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.